Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program (PR...
                   
yahoo.com     May 22, 2008            

Ardea Biosciences, Inc. today announced preclinical data on its lead non-nucleoside reverse transcriptase inhibitor candidate, RDEA806, demonstrating no reproductive toxicity. In addition, novel second-generation NNRTI, RDEA427, was selected as a development candidate for the potential treatment... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

Kenya: HIV Infected Mothers Given the Nod to Breastfeed, But

allafrica.com     1 hr ago          

Posted to the web 24 July 2008 Casper Waithaka Nairobi HIV infected mothers should breastfeed their babies, but only if they are on anti-retroviral drugs, researchers have now said. The baby should also be on drugs to prevent...                

comments

Australia, Fiji establish coalition to address impact of HIV/AIDS on business

news-medical.net     2 hrs ago   2 related          

The Fiji Australia Business Council and UNAIDS on Monday agreed to a partnership under which they will develop a business coalition in Fiji to strengthen the private sector's response to HIV/AIDS, the Fiji Times reports (Fiji...                

comments

Groundbreaking online video series tries to help stop HIV among gay men

edgeboston.com     2 hrs ago          

Josh is a young gay man living in Manhattan who had unsafe sex-and according to research, his story is startlingly effective in reducing high-risk sexual behavior among other gay men. Josh is the fictional star of HIV "Is Still...                

comments

Patients often hide sexual orientation

upi.com     2 hrs ago   4 related          

NEW YORK, July 24 (UPI) -- Thirty-nine percent of men in New York City who have sex with other men do not disclose their sexual orientation to their doctors, health officials said. Healthcare providers, who know about their...                

comments